Claros Mortgage Trust, Inc.
NYSE:CMTGREIT - Mortgage
+$0.09 today
- Market cap
- $211.63M
- Beta
- 1.15
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$3.31
Volume 0.66M
Average 0.48M
CMTG EBITDA Margin
EBITDA as a percentage of revenue.
Claros Mortgage Trust, Inc.NYSE: CMTG
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin narrows to -128.9%
EBITDA Margin was -128.9% in Q1 FY2026, down 102.8 pp from a year earlier. On a trailing-twelve-month basis it was -120.1%, down 102.5 pp year over year. Over 3 fiscal years it narrowed by 157.8 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 2 analysts of -203.6% for the fiscal year ending Dec 2026, down from -113.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -128.9%+162.3 pp QoQ
- Last fiscal yearDec 2025
- -113.3%-8.8 pp YoY
- LTMMar 2026
- -120.1%-102.5 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -102.8 pp | +49.5 pp | +152.3 pp |
| 1 year | -8.8 pp | -90.3 pp | -81.5 pp |
| 3 years | -157.8 pp | +70.6 pp | +228.4 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -113.3%
- Year-over-year change
- -8.8pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -113.3% | -8.8pp |
| FY2024 | 2024-12-31 | -104.6% | -247.6pp |
| FY2023 | 2023-12-31 | 143.0% | +98.5pp |
| FY2022 | 2022-12-31 | 44.5% | -38.1pp |
| FY2021 | 2021-12-31 | 82.5% | — |
EBITDA Margin vs competitors
How CMTG compares with its peers on the latest reported figures
- CMTG's LTM Mar 2026 EBITDA Margin of -120.1% is the 8th highest of the 9 companies compared; the peer median is 45.6%.
- Its year-over-year change of -102.5 pp is the 8th highest of 9, against a peer median of -27.3 pp.
- Over three fiscal years its change of -157.8 pp compares with a peer median of +0.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 268.6% | -85.1 pp | +105.5 pp | |
| LTM Mar 2026 | 104.2% | +16.5 pp | -8.2 pp | |
| LTM Mar 2026 | 61.0% | -2.1 pp | +18.8 pp | |
| LTM Mar 2026 | 47.8% | -27.7 pp | -2.7 pp | |
| LTM Mar 2026 | 43.5% | -26.9 pp | +3.7 pp | |
NHPAPNational Healthcare Properties, Inc. | LTM Mar 2026 | 24.9% | +1.8 pp | +13.3 pp |
| LTM Mar 2026 | 0.6% | -43.1 pp | -148.6 pp | |
| LTM Mar 2026 | -120.1% | -102.5 pp | -157.8 pp | |
| LTM Mar 2026 | -131.2% | -1817.6 pp | -113.8 pp | |
| Peer median (excluding CMTG) | 45.6% | -27.3 pp | +0.5 pp | |
Competitors are the stored peer set for CMTG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 215.02M | 270.2M | 129.83M | 170.67M | 430.48M |
| Cost of Revenue | 0 | 0 | 49.5M | 105.97M | 804.68M |
| Gross Profit | 215.02M | 270.2M | 80.33M | (48.81M) | (374.2M) |
| Gross Margin | 100.0% | 100.0% | 61.9% | -28.6% | -86.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 21.4M | 26.14M | 33.2M | 15.71M | 34.13M |
| Operating Expenses | 215.02M | 270.2M | 72.92M | 70.04M | 114.87M |
| Depreciation & Amortization | 7.11M | 8.04M | 9.29M | 11.91M | 1.2M |
| EBITDA | 177.5M | 120.2M | 185.65M | (178.46M) | (487.87M) |
| EBITDA Margin | 82.5% | 44.5% | 143.0% | -104.6% | -113.3% |
| Operating Income | 0 | 0 | 107.53M | (190.36M) | (489.07M) |
| Operating Margin | 0.0% | 0.0% | 82.8% | -111.5% | -113.6% |
| Interest Income | 415.26M | 470.67M | 697.87M | 601.41M | 389.51M |
| Interest Expense | 196.23M | 261.11M | 494.14M | 466.96M | 338.15M |
| Other Income / Expenses | 170.39M | 112.16M | (101.5M) | (30.9M) | (35.69M) |
| Income Before Tax | 170.39M | 112.16M | 6.03M | (221.27M) | (489.07M) |
| Pre-Tax Margin | 79.2% | 41.5% | 4.6% | -129.6% | -113.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 170.55M | 112.06M | 6.03M | (221.27M) | (489.07M) |
| Net Margin | 79.3% | 41.5% | 4.6% | -129.6% | -113.6% |
| EPS (Basic) | 1.27 | 0.80 | 0.02 | (1.60) | (3.48) |
| EPS (Diluted) | 1.27 | 0.80 | 0.02 | (1.60) | (3.48) |
| Weighted Avg Shares | 134.54M | 139.31M | 138.62M | 139.23M | 140.56M |
| Weighted Avg Shares (Diluted) | 134.54M | 139.31M | 138.62M | 139.23M | 140.56M |
Claros Mortgage Trust, Inc.
NYSE:CMTG
Intrinsic Alpha fair value
Locked
Current Price
$1.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.